Pais / Región
Paises

Provincias / Departamentos
Colombia Colombia
Argentina Argentina
Canada Canada
Chile Chile
Ecuador Ecuador
España España
Guatemala Guatemala
Honduras Honduras
Mexico Mexico
Panama Panama
Paraguay Paraguay
United States United States
Uruguay Uruguay
Categorias / Industrias
Publication: 0000-00-00 00:00:00
United States SAM

Naloxone and compounded pharmaceuticals

Process Number W81K0022Q0012

USA

Dates:


Notice ID:

W81K0022Q0012

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

W40M USA HLTH CONTRACTING ACT

Office:

W40M USA HLTH CONTRACTING ACT

General Information:


All Dates/Times are:

(utc-06:00) central standard time, chicago, usa

Updated Published Date:

(utc-06:00) central standard time, chicago, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

dec 23, 2021 10:00 am cst

Inactive Policy:

15 days after response date

Initiative:
  • None***--***

Classification:


Original Set Aside:

total small business set-aside (far 19.5)

Product Service Code:

6505 - drugs and biologicals

NAICS Code:

325412 - pharmaceutical preparation manufacturing

Description:


Original Set Aside:

Regional Health Contracting Office-Central, Joint Base San Antonio-Fort Sam Houston, Texas intends to award a sole source contract to Wells Pharma of Houston, LLC. for Naloxone and compounded pharmaceuticals. Naloxone and compounded pharmaceuticals must meet the below salient characteristics: Naloxone 1mg/mL 2mL Oral Syringe Will contain a solution of Naloxone 1mg/ml packaged in 2mL oral syringe Will be packaged in an oral syringe with a tamper evident cap and without a luer lock tip Will be labeled for oral use only Must have a Beyond Use Date of no less than 30 days Ketamine 10mg/mL in Normal Saline 5mL in 10mL OR Syringe Will contain ketamine 10mg/mL mixed with Normal Saline 5mL packaged in a 10mL OR syringe Will have a label affixed to each syringe specifying the contents Must have a Beyond Use Date of no less than 30 days Ketamine 10mg/mL in Normal Saline 10mL in 10mL OR Syringe Will contain ketamine 10mg/mL mixed with Normal Saline 10mL packaged in a 10mL OR syringe Will have a label affixed to each syringe specifying the contents Must have a Beyond Use Date of no less than 30 days Norepinephrine 4mg in D5W 250mL bag Will contain norepinephrine 4mg added to 250mL bag of dextrose 5% in water Will have a label affixed to each bag specifying the contents Must have a Beyond Use Date of no less than 30 day Norepinephrine 8mg in D5W 250mL bag Will contain norepinephrine 8mg added to 250mL bag of dextrose 5% in water Will have a label affixed to each bag specifying the contents Must have a Beyond Use Date of no less than 30 days Award will be made on or about 23 December 2021. The primary NAICS code for the requirement 325412 with a size standard of 1,250 employees. This notice is neither a request for quotes nor a solicitation of offers; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency for future requirements.

Attachments / Links:


Document Size Updated date Download

Contact Information:


REGIONAL HEALTH CONTRACT OFF CENTRA 2539 GARDEN AVENUE

JBSA FT SAM HOUSTON , TX 78234-0000

USA

Primary Point of Contacts:

Cathy Harris